NCT06787222View on ClinicalTrials.gov

Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 3, 2024

Primary Completion Date

August 25, 2025

Study Completion Date

October 31, 2025

Conditions
Acne Vulgaris
Interventions
DRUG

tretinoin 0.025% + Z. officinale patch

Material used for patch formulation were 3,15 grams of polyvinyl alcohol, 4,2 grams of polyvinyl pyrrolidone, 12,6 ml distilled water, and 1,05 grams of Z. officinale extract.

DRUG

tretinoin 0.025% cream

no Z. officinale patch applied after tretinoin 0.025% application

Trial Locations (1)

Unknown

Doctoral Programme, Faculty of Medicine, Hasanuddin University, Makassar

All Listed Sponsors
lead

Hasanuddin University

OTHER

NCT06787222 - Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome | Biotech Hunter | Biotech Hunter